FDA announces immediate market withdrawal of Zantac/ranitidine medications

Apr 01, 2020 - 04:00 PM
fda-alert-recall-compounded-drugs

The Food and Drug Administration today announced it is requesting manufacturers immediately withdraw all prescription and over-the-counter ranitidine drugs (commonly known by the brand name Zantac) from the market.

This is the latest step in an ongoing investigation of the carcinogenic contaminant N-Nitrosodimethylamine (NDMA), which in some ranitidine products increases over time and when stored at higher than room temperatures to unacceptable levels.

The FDA advised consumers taking OTC ranitidine to stop taking any tablets or liquid they currently have, dispose of them properly and not buy more; patients taking prescription ranitidine should speak with their health care professional about other treatment options before stopping the medicine.

Related News Articles

Headline
FDA doesn’t appeal court ruling invalidating lab-developed tests rule, effectively eliminating it
A 60-day appeal window has passed for the Food and Drug Administration to appeal a federal court ruling that invalidated its final rule to regulate laboratory-…
Headline
AHA makes 100 suggestions to Trump administration on providing regulatory relief 
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
AHA launches online collaborative focused on quality improvement
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at…
Headline
Court strikes down FDA rule on regulating lab-developed tests
The U.S. District Court for the Eastern District of Texas March 31 ruled that the Food and Drug Administration does not have the authority to regulate…
Headline
AHA webpage highlights how hospitals and health systems integrate patient safety
As part of the AHA's Patient Safety Initiative, a dedicated webpage features case studies showing how hospitals and health systems across the nation are…
Blog
Can Collaborative Efforts to Improve Device Design Improve Safety?
Public
During World War II, the U.S. Army Air Corps depended on its B-17 bombers to inflict incredible damage against the Axis powers in Europe. These “Flying…